| Literature DB >> 29383665 |
Panagiotis Papatheodorou1,2,3, Holger Barth4, Nigel Minton5, Klaus Aktories6.
Abstract
Research on the human gut pathogen Clostridium difficile and its toxins has gained much attention, particularly as a consequence of the increasing threat to human health presented by emerging hypervirulent strains. Toxin A (TcdA) and B (TcdB) are the two major virulence determinants of C. difficile. Both are single-chain proteins with a similar multidomain architecture. Certain hypervirulent C. difficile strains also produce a third toxin, namely binary toxin CDT (Clostridium difficile transferase). As C. difficile toxins are the causative agents of C. difficile-associated diseases (CDAD), such as antibiotics-associated diarrhea and pseudomembranous colitis, considerable efforts have been expended to unravel their molecular mode-of-action and the cellular mechanisms responsible for their uptake. Notably, a high proportion of studies on C. difficile toxins were performed in European laboratories. In this chapter we will highlight important recent advances in C. difficile toxins research.Entities:
Keywords: Bacterial disease; Bacterial toxins; Clostridium difficile; Toxin receptor; Toxin uptake
Mesh:
Substances:
Year: 2018 PMID: 29383665 DOI: 10.1007/978-3-319-72799-8_6
Source DB: PubMed Journal: Adv Exp Med Biol ISSN: 0065-2598 Impact factor: 2.622